
Ahmedabad, Gujarat, India
Dr. Swati H. Shah is a Pelvic and Uro-Oncosurgeon with 18+ years of experience in cancer surgery and 13+ years of experience in robotic surgery, with a focused practice in urological and pelvic cancers.
She specialises in the surgical management of urinary bladder, prostate, kidney, testicular, penile and complex pelvic cancers, using open, laparoscopic and robotic approaches according to the cancer stage, anatomy, previous treatment and patient’s overall condition.
Her practice combines uro-oncology, robotic surgery and complex pelvic oncology, with particular expertise in technically demanding cancer operations where the urinary tract, pelvic organs, lymph nodes and surrounding structures may be involved.
She practices at Apollo Hospital International, Ahmedabad, and at Shah’s Cancer & Robotic Surgery Centre, Gota, Ahmedabad.
Dr. Swati Shah completed her:
Her surgical training included extensive exposure to urological cancers, pelvic malignancies and complex cancer surgery.
During her specialist surgical oncology training, she developed focused experience in the management of prostate, kidney, bladder and other uro-oncological cancers.
She was also part of a high-volume robotic oncology environment in Delhi and gained early experience with robotic uro-oncological surgery before robotic cancer surgery became established in Gujarat.
Dr. Swati Shah has been involved in the surgical treatment of urinary bladder cancer since 2008.
She has been performing:
She has performed approximately 150 bladder cancer surgical procedures, including endoscopic, laparoscopic, open and robotic procedures.
Her bladder cancer practice includes both the removal of the cancer and, when the bladder needs to be removed, planning and performing appropriate urinary reconstruction.
Dr. Shah performs and has experience with:
A major area of Dr. Shah’s expertise is robotic radical cystectomy with urinary reconstruction.
She has been performing robotic radical cystectomy since 2013, with experience in robotic cystoprostatectomy, pelvic lymph-node dissection and urinary diversion.
Her surgical experience includes neobladder reconstruction, including completely robotic approaches in selected patients.
Her approach is not limited to removal of the urinary bladder. Treatment planning also considers what happens after cystectomy:
Cancer removal → lymph-node dissection → urinary diversion/reconstruction → functional recovery
Depending on the patient’s cancer, anatomy, age, general health, renal function, urethral suitability and other factors, urinary reconstruction may include an ileal conduit or an orthotopic neobladder.
Dr. Shah’s combined background in uro-oncology and gynecologic/pelvic oncology provides experience in cancers involving multiple pelvic organs.
She manages selected complex pelvic cancers involving:
This experience is particularly relevant when cancer surgery requires detailed understanding of the relationships between the urinary, reproductive and gastrointestinal organs.
Her practice includes selected pelvic exenteration and anterior exenteration procedures, where radical cystectomy forms part of a larger cancer operation.
Dr. Shah also performs selected complex pelvic cancer operations in patients who have previously undergone treatment such as:
Such cases require detailed review of imaging, previous treatment, tumour location and the possibility of achieving complete cancer removal.
Her published work on pelvic exenteration for recurrent or persistent cervical cancer evaluated 25 patients who underwent preoperative PET-CT and pelvic MRI for assessment of pelvic disease and surgical resectability.
The study reported R0 resection in all 25 patients, robotic surgery in selected patients, major complications in 8%, and no perioperative mortality.
The publication supports the concept that, in carefully selected patients with recurrent or persistent cervical cancer confined to the pelvis, radical pelvic surgery can offer a meaningful possibility of long-term disease control and cure.
This work is relevant to her broader expertise in complex pelvic cancer surgery involving radical cystectomy and urinary diversion, rather than being represented as a bladder-cancer-specific publication.
Bladder cancer treatment is not always a single-operation decision.
Treatment may involve:
Dr. Shah follows a multidisciplinary approach in which the treatment plan is based on the patient’s tumour stage, histopathology, imaging, previous treatment, fitness and overall goals.
For appropriate patients, the pathway may involve:
Haematuria / bladder lesion → cystoscopy → TURBT → histopathology → staging → multidisciplinary treatment planning → systemic therapy and/or surgery → urinary reconstruction → follow-up
The exact sequence is individualised according to the type and stage of bladder cancer.
Dr. Shah has been performing robotic cancer surgery since 2013.
Her robotic uro-oncology experience includes:
She has performed approximately 650 robotic uro-gynaecologic cancer surgeries as part of her broader robotic oncology experience.
Dr. Shah is actively involved in academic uro-oncology, robotic surgery education and surgical teaching.
Her academic work includes:
Her academic presentations have included uro-oncological and robotic procedures involving kidney and bladder cancer, as well as prostate, testicular and complex pelvic cancers.
Dr. Shah has presented robotic cystectomy, cystoprostatectomy and neobladder surgery through surgical videos, academic meetings, webinars and teaching sessions.
Her robotic uro-oncology surgical work has been presented to professional audiences in different cities across India and through online academic platforms.
These presentations focus on:
Her surgical videos provide professional audiences with case-based demonstrations of advanced robotic uro-oncological techniques.
Dr. Shah has participated as a faculty member, speaker, moderator or presenter at professional surgical and oncology meetings.
Her academic involvement includes conferences and forums associated with:
Documented academic activities include robotic uro-oncology master video sessions at ASICON, RUFCON and IASOCON, a best video presentation at NATCON 2021, and invited faculty participation at meetings including ENDO LAP MAMC and the West Zone Urology Society of India.
She has also participated in national multidisciplinary oncology panel discussions and robotic surgery workshops.
Dr. Shah has contributed to surgical education by teaching urologists and surgeons from across India about robotic uro-oncology.
Her teaching includes:
She has conducted and participated in robotic surgery workshops, surgical video sessions, webinars and academic teaching programmes.
Her teaching philosophy emphasises that robotic surgery is a tool used by the surgeon, and that good robotic cancer surgery depends on oncological principles, anatomical understanding, appropriate patient selection and meticulous surgical technique.
Dr. Shah has also developed multidisciplinary academic platforms bringing different cancer specialists together for focused discussion of pelvic malignancies.
PROM brings together specialists such as radiologists and oncologists to discuss pelvic cancer imaging, diagnosis, staging, treatment planning and complex cases.
The programme includes discussion of urological and pelvic cancers, including renal and bladder tumours.
POINT is a multidisciplinary academic platform bringing together pathology and oncology perspectives for discussion of tumour biology, pathology, treatment decisions, immunology and newer systemic therapies.
The programme has included discussions relevant to uro-oncology and pelvic cancers, including kidney and bladder malignancies.
These initiatives reflect Dr. Shah’s interest not only in performing surgery, but also in improving multidisciplinary cancer decision-making and cross-specialty education.
Dr. Shah has received recognition for scientific paper presentations at professional meetings including:
She has also received recognition for surgical video presentations, including the Best Video Presentation on Robotic Retroperitoneal Lymph Node Dissection at NATCON 2021, New Delhi.
She is the author/co-author of multiple publications in national and international journals related to:
She has also served in academic/reviewer roles for oncology journals.
Dr. Shah is associated with professional organisations including:
Dr. Shah’s approach to cancer surgery is based on four principles:
The primary objective is appropriate oncological clearance based on the cancer type and stage.
Not every bladder cancer requires the same operation. Treatment is planned according to pathology, stage, imaging, previous treatment, anatomy and patient fitness.
When oncologically safe, preservation of healthy organs and important functions is considered.
For patients requiring bladder removal, treatment planning extends beyond cancer removal to urinary reconstruction and postoperative quality of life.
Patients seeking bladder cancer treatment may need answers to several different questions:
Dr. Shah’s bladder cancer practice is designed to address these decisions through stage-based treatment planning, cancer-focused surgery, urinary reconstruction and multidisciplinary care.
Dr. Shah’s bladder cancer website includes a growing clinical library consisting of:
These cases demonstrate the range of bladder cancer presentations and surgical approaches rather than presenting robotic surgery as a one-size-fits-all treatment.
Dr. Swati H. Shah
Pelvic & Uro-Oncosurgeon | Robotic Uro-Oncologic Surgeon
Primary areas of bladder cancer expertise:
TURBT | Radical Cystectomy | Robotic Radical Cystectomy | Radical Cystoprostatectomy | Pelvic Lymph-Node Dissection | Ileal Conduit | Neobladder | Robotic Intracorporeal Reconstruction | Complex Pelvic Cancer Surgery | Recurrent Pelvic Cancer Surgery
Practice locations:
Shah’s Cancer & Robotic Surgery Centre, Gota, Ahmedabad
Apollo Hospital International, Ahmedabad/Gandhinagar
In this case, laparoscopic surgery was performed for bladder cancer, with careful dissection and safe removal of the tumour specimen. Minimally invasive techniques may offer advantages such as smaller incisions, less postoperative pain, reduced blood loss and earlier mobilization, although the benefits and suitability depend on the type, stage and location of the cancer and the patient’s overall condition.
The tumour specimen was removed safely, and the patient had a smooth postoperative recovery and was discharged on the fifth day.
The smaller scars are one visible benefit of minimally invasive surgery, but the primary goal remains complete and safe cancer treatment. The choice between laparoscopic, robotic, open or other approaches should always be individualized based on the cancer and the patient.
The goal of radical cystectomy is to achieve complete removal of the cancer with adequate surgical margins while addressing possible spread to regional lymph nodes. Careful dissection and attention to anatomical planes are essential to ensure a thorough and safe oncological procedure.
Robotic surgery can provide a magnified 3D view, precise instrument control and enhanced dexterity, which can be particularly useful during complex pelvic cancer surgery. However, the choice of surgical approach depends on the cancer stage, anatomy, patient’s overall condition and the expertise of the surgical team.
The surgical specimen is carefully examined by the pathology team to assess the tumour, lymph nodes and surgical margins. Clear margins are an important component of complete cancer surgery.
Swasth Parivar: every week, practical advice on recovery, diet and warning signs. No advertising. Stop any time.
Your number is used for these updates and for the clinic to reach you. It is never sold or passed on. To stop, reply STOP on WhatsApp.